In focus
Latest feed
Pfizer Shares Waver After Seagen’s Mixed Top‑Line Data on Origin Cancer Therapy
Pfizer Shares Slip After Seagen’s Origin Cancer Drug Delivers Mixed Top‑line Results
Jazz Pharma’s Promising Lung‑Cancer Candidate Stumbles in Late‑Stage Study
Eli Lilly's Cancer Revolution: How Loxo Oncology Reshaped an Empire
